Redefining Metabolic Healthcare
Julian Mercer, M.S.
Julian Mercer is the Lead Bio-Systems Analyst and Clinical Data Director for TelehealthFX. With an advanced background in cellular endocrinology and pharmacokinetic optimization, Julian specializes in translating complex medical data—such as GLP-1 receptor agonist pathways and transdermal diffusion mechanics—into actionable clinical strategies.
His work focuses exclusively on metabolic syndrome, insulin resistance, and the mitigation of adverse effects during extreme fat loss protocols (such as sarcopenia prevention via peptide therapies). Julian oversees the clinical integrity of all educational content published on the TelehealthFX platform, ensuring strict adherence to the latest peer-reviewed literature and FDA regulatory guidelines.
Our Mission & Clinical Standards
TelehealthFX was founded to disrupt the chaotic, predatory landscape of online medical weight loss. As the demand for GLP-1 medications skyrocketed, patients were abandoned by traditional healthcare and preyed upon by illicit compounding mills.
Our mission is absolute clinical transparency. We partner exclusively with fully verified, U.S.-licensed 503A pharmacies to provide safe, FDA-compliant medications. We do not utilize dangerous salt formulations (like semaglutide sodium) or unverified research chemicals. Every patient undergoes a rigorous medical evaluation and receives 1-on-1 clinician onboarding.
U.S. Pharmacies
We only utilize state-licensed 503A compounding facilities that undergo rigorous 3rd-party sterility testing.
Clinical Oversight
No chatbots or auto-approvals. You interact directly with licensed healthcare providers in your state.
Zero Hidden Fees
We abolished the predatory membership fee model. The price of your medication includes your clinical care.